IFNARBYN Trademark

Trademark Overview

On Monday, June 26, 2017, a trademark application was filed for IFNARBYN with the United States Patent and Trademark Office. The USPTO has given the IFNARBYN trademark a serial number of 87505411. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2020. This trademark is owned by AstraZeneca AB. The IFNARBYN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
ifnarbyn

General Information

Serial Number87505411
Word MarkIFNARBYN
Filing DateMonday, June 26, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 1, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, January 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 13, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2019EXTENSION 2 GRANTED
Thursday, May 30, 2019EXTENSION 2 FILED
Thursday, May 30, 2019TEAS EXTENSION RECEIVED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 27, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 27, 2018EXTENSION 1 GRANTED
Tuesday, November 27, 2018EXTENSION 1 FILED
Tuesday, November 27, 2018TEAS EXTENSION RECEIVED
Tuesday, June 12, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 14, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 9, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, March 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 5, 2018ASSIGNED TO LIE
Tuesday, February 20, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 24, 2017NON-FINAL ACTION E-MAILED
Sunday, September 24, 2017NON-FINAL ACTION WRITTEN
Friday, September 22, 2017ASSIGNED TO EXAMINER
Saturday, July 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 29, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

ifnarbyn diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal